Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:05 AM
Ignite Modification Date:
2025-12-25 @ 4:05 AM
NCT ID:
NCT06158802
Eligibility Criteria:
Inclusion Criteria:
* Information and non-opposition of major patients and holders of parental authority of minor patients and minor patients
* Girls and young women aged 11 to 20
* To be followed at the Necker-Enfants Malades Hospital ("chronic condition" group)
* To be followed at the Specialized Medical Center for Children and Adolescents ("control" group)
* Have a chronic condition ("chronic condition" group) :
* Diabetes type 1
* Metabolic diseases
* Patients followed in immuno-hematology
* Cystic Fibrosis
* Sickle
* Kidney transplant
* Heart Disease
* Inflammatory bowel diseases
* Rare anorectal and pelvic anomalies
* Live in France
* Comprehension of the French language (oral and written)
Exclusion Criteria:
* Have a contraindication to the HPV vaccine - Gardasil 9 (Vidal Hoptimal, 2018)
* Have a contraindication to the HPV vaccine - Gardasil (Vidal Hopitmal, 2018)
* Have a contraindication to HPV vaccine - Cervarix (Vidal Hoptimal, 2018)
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
11 Years
Maximum Age:
20 Years
Study:
NCT06158802
Study Brief:
Protocol Section:
NCT06158802